Automated Insulin Delivery in Pregnant Patients With Type 1 Diabetes With Extension Into Outpatient at Home

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 27, 2020

Primary Completion Date

October 5, 2022

Study Completion Date

October 5, 2022

Conditions
Type 1 DiabetesPregnancy
Interventions
DEVICE

Automated Insulin Delivery

"Participants will use the Automated Insulin Delivery (AID) iAPS system for 48-60 hours in a medically supervised session.~For subjects who wish to continue use of the system, they will be offered the option of continuing use of the system at home in an extension phase, for the rest of their pregnancy."

Trial Locations (3)

10029

Icahn School of Medicine at Mount Sinai, New York

55905

Mayo Clinic, Rochester

93105

Sansum Diabetes Research Institute, Santa Barbara

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mayo Clinic

OTHER

collaborator

Harvard University

OTHER

collaborator

Icahn School of Medicine at Mount Sinai

OTHER

lead

Sansum Diabetes Research Institute

OTHER